Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.

NCT05992337 is registered in ClinicalTrials.gov with Cardiology Prague as lead sponsor.

NCT NCT05992337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05992337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.
Lead sponsor
Cardiology Prague
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2021
Completion date
January 31, 2025
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiotoxicity, chemotherapy effect, chemotherapy induced systolic dysfunction